{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-23-000502","form_type":"8-K","ticker":"CFOR","cik":"0001293818","company_name":"CapForce Inc.","filed_at":"2023-04-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.298669+00:00","generated_at":"2026-06-16T23:25:31.517547+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"OpGen signs non-exclusive distribution deal with Fisher Healthcare for Unyvero platform in U.S.","bullets":["Fisher Healthcare becomes non-exclusive national distributor for Unyvero A50 platform alongside OpGen's direct U.S. sales.","Initial focus on FDA-cleared Unyvero LRT (BAL) cartridge for hospitalized pneumonia patients and RUO Unyvero UTI for UTIs.","Unyvero LRT is first FDA-cleared IVD for bacterial pneumonia and antimicrobial resistance markers.","Unyvero UTI pivotal trial completed; De Novo classification request submitted to FDA.","Deal aims to expand Unyvero commercial presence and drive revenue growth in the U.S."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-23-000502","json":"https://secwatch.observer/filing/0001079973-23-000502.json","markdown":"https://secwatch.observer/filing/0001079973-23-000502.md","text":"https://secwatch.observer/filing/0001079973-23-000502.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1293818/000107997323000502/0001079973-23-000502-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1293818/000107997323000502/opgen_8k-041923.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T23:25:31.517547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}